DK2079441T3 - Topisk antibiotisk sammensætning til forebyggelse af Lyme's sygdom - Google Patents

Topisk antibiotisk sammensætning til forebyggelse af Lyme's sygdom

Info

Publication number
DK2079441T3
DK2079441T3 DK08786388.2T DK08786388T DK2079441T3 DK 2079441 T3 DK2079441 T3 DK 2079441T3 DK 08786388 T DK08786388 T DK 08786388T DK 2079441 T3 DK2079441 T3 DK 2079441T3
Authority
DK
Denmark
Prior art keywords
disease
antibiotic composition
topical antibiotic
prevent lyme
lyme
Prior art date
Application number
DK08786388.2T
Other languages
English (en)
Inventor
Gustave Huber
Uta Huettenes
Bidder Caroline Roosens-Von
Original Assignee
Ixodes Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ixodes Gmbh filed Critical Ixodes Gmbh
Application granted granted Critical
Publication of DK2079441T3 publication Critical patent/DK2079441T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK08786388.2T 2007-07-25 2008-07-24 Topisk antibiotisk sammensætning til forebyggelse af Lyme's sygdom DK2079441T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113143 2007-07-25
PCT/EP2008/059696 WO2009013331A1 (en) 2007-07-25 2008-07-24 Topical antibiotic composition for the prevention of lyme disease

Publications (1)

Publication Number Publication Date
DK2079441T3 true DK2079441T3 (da) 2010-12-13

Family

ID=39149162

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08786388.2T DK2079441T3 (da) 2007-07-25 2008-07-24 Topisk antibiotisk sammensætning til forebyggelse af Lyme's sygdom

Country Status (15)

Country Link
US (2) US8710019B2 (da)
EP (1) EP2079441B1 (da)
JP (1) JP2010534221A (da)
AT (1) ATE481964T1 (da)
AU (1) AU2008280131B9 (da)
CA (1) CA2694403C (da)
CY (1) CY1110971T1 (da)
DE (1) DE602008002692D1 (da)
DK (1) DK2079441T3 (da)
ES (1) ES2349906T3 (da)
HR (1) HRP20100699T1 (da)
PL (1) PL2079441T3 (da)
PT (1) PT2079441E (da)
SI (1) SI2079441T1 (da)
WO (1) WO2009013331A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
WO2015171225A1 (en) * 2014-05-09 2015-11-12 The Johns Hopkins University Identification of novel anti-persister activity for borrelia burgdorferi
EP3307275B1 (en) * 2015-06-10 2021-05-26 Piedmont Animal Health Inc. Injectable antibiotic formulations and use thereof
EP3252470B1 (en) 2016-06-03 2020-07-29 Te?ted Oy A method and a solid support for detecting tick-borne microbes in a biological sample

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748399C2 (de) * 1976-11-01 1983-09-15 The Procter & Gamble Co., 45202 Cincinnati, Ohio Antimikrobielles Mittel zur örtlichen Anwendung
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
IL132096A0 (en) * 1997-03-31 2001-03-19 Johnson & Johnson Consumer Solvent system for enhanced penetration of pharmaceutical compounds
US7179475B1 (en) * 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
US6589568B2 (en) * 2001-02-16 2003-07-08 Nurad, Inc. Therapeutic body lotion containing alkali metal hypohalite
WO2003039418A1 (en) * 2001-11-06 2003-05-15 Maxim Pharmaceuticals, Inc. Compositions for the treatment of infectious diseases
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Also Published As

Publication number Publication date
HRP20100699T1 (hr) 2011-01-31
US20100130437A1 (en) 2010-05-27
AU2008280131A1 (en) 2009-01-29
SI2079441T1 (sl) 2010-12-31
ATE481964T1 (de) 2010-10-15
CA2694403A1 (en) 2009-01-29
US20140194375A1 (en) 2014-07-10
JP2010534221A (ja) 2010-11-04
ES2349906T3 (es) 2011-01-12
EP2079441B1 (en) 2010-09-22
PL2079441T3 (pl) 2011-02-28
US8710019B2 (en) 2014-04-29
DE602008002692D1 (de) 2010-11-04
CA2694403C (en) 2013-09-24
WO2009013331A1 (en) 2009-01-29
CY1110971T1 (el) 2015-06-11
PT2079441E (pt) 2010-11-19
AU2008280131A8 (en) 2010-03-04
AU2008280131B2 (en) 2014-06-26
US9610244B2 (en) 2017-04-04
EP2079441A1 (en) 2009-07-22
AU2008280131B9 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
EA200802166A1 (ru) Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
GT200600520A (es) Agentes antibacterianos
UA107783C2 (en) Isoindoline compounds for use in treating cancer
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
EA200970542A1 (ru) ИНГИБИТОРЫ ДЕЙСТВИЯ Akt
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
BRPI0922220B8 (pt) uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
BRPI0718688A8 (pt) Composições de baixa irritação e métodos para preparar as mesmas
ATE433980T1 (de) Gyraseinhibitoren und deren verwendungen
TW200714604A (en) Substituted heterocycles and the uses thereof
HK1133787A1 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
WO2007143607A3 (en) Method of treating atrophic vaginitis
TN2009000398A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds
BRPI0815920A2 (pt) Composto, composição farmacêutica, e, uso do composto.
WO2007122581A3 (en) Compositions and kits of phenylephrine
TN2010000074A1 (en) Cyclic depsipeptides
BR112012011485A2 (pt) "composições e métodos para tratar náusea e vômito centralmente mediados".
ATE531721T1 (de) Cyanoaminochinolone als gsk-3-inhibitoren
ATE522500T1 (de) Amidderivate als ionenkanalliganden sowie pharmazeutische zusammensetzungen und verwendungsverfahren dafür
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
DK2079441T3 (da) Topisk antibiotisk sammensætning til forebyggelse af Lyme's sygdom
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis